{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T22:46:19Z","timestamp":1770763579865,"version":"3.50.0"},"reference-count":158,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>The current health crisis caused by coronavirus 2019 (COVID-19) and associated pathogens emphasize the urgent need for vaccine systems that can generate protective and long-lasting immune responses. Vaccination, employing peptides, nucleic acids, and other molecules, or using pathogen-based strategies, in fact, is one of the most potent approaches in the management of viral diseases. However, the vaccine candidate requires protection from degradation and precise delivery to the target cells. This can be achieved by employing different types of drug and vaccine delivery strategies, among which, nanotechnology-based systems seem to be more promising. This entry aims to provide insight into major aspects of vaccine design and formulation to address different diseases, including the recent outbreak of SARS-CoV-2. Special emphasis of this review is on the technical and practical aspects of vaccine construction and theranostic approaches to precisely target and localize the active compounds.<\/jats:p>","DOI":"10.3390\/biomedicines9050520","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T11:10:27Z","timestamp":1620299427000},"page":"520","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Methodical Design of Viral Vaccines Based on Avant-Garde Nanocarriers: A Multi-Domain Narrative Review"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8502-9106","authenticated-orcid":false,"given":"Ehsan","family":"Raoufi","sequence":"first","affiliation":[{"name":"Department of Medical Biotechnology, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran 1449614535, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahar","family":"Bahramimeimandi","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran 1449614535, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Salehi-Shadkami","sequence":"additional","affiliation":[{"name":"Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran 1449614535, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patcharida","family":"Chaosri","sequence":"additional","affiliation":[{"name":"Supreme NanoBiotics Co. Ltd. and Supreme Pharmatech Co. Ltd., 399\/90-95 Moo 13 Kingkaew Rd. Soi 25\/1, T. Rachateva, A. Bangplee, Samutprakan 10540, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4118-1544","authenticated-orcid":false,"given":"M. R.","family":"Mozafari","sequence":"additional","affiliation":[{"name":"Supreme NanoBiotics Co. Ltd. and Supreme Pharmatech Co. Ltd., 399\/90-95 Moo 13 Kingkaew Rd. Soi 25\/1, T. Rachateva, A. Bangplee, Samutprakan 10540, Thailand"},{"name":"Australasian Nanoscience and Nanotechnology Initiative (ANNI), Monash University LPO, Clayton, VIC 3168, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1126\/science.1094823","article-title":"How Viruses Enter Animal Cells","volume":"304","author":"Smith","year":"2004","journal-title":"Science"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.tim.2005.04.003","article-title":"Here a virus, there a virus, everywhere the same virus?","volume":"13","author":"Breitbart","year":"2005","journal-title":"Trends Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"9504","DOI":"10.1093\/nar\/gku628","article-title":"CRISPR-Cas: An Efficient Tool for Genome Engineering of Virulent Bacteriophages","volume":"2","author":"Martel","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrmicro2315","article-title":"Bacteriophage Resistance Mechanisms","volume":"8","author":"Labrie","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.5423\/PPJ.RW.04.2020.0074","article-title":"Bacteriophage usage for bacterial disease management and diagnosis in plants","volume":"36","author":"Vu","year":"2020","journal-title":"Plant Pathol. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.mib.2008.09.004","article-title":"Bacteriophage genomics","volume":"11","author":"Hatfull","year":"2008","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/mpp.12851","article-title":"Host factors against plant viruses","volume":"20","year":"2019","journal-title":"Mol. Plant Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Garcia-Ruiz, H. (2018). Susceptibility Genes to Plant Viruses. Viruses, 10, Available online: http:\/\/www.mdpi.com\/1999-4915\/10\/9\/484.","DOI":"10.3390\/v10090484"},{"key":"ref_9","unstructured":"(2021, March 01). Plant Virology\u2014Roger Hull\u2014Google Books. Available online: https:\/\/books.google.com\/books?hl=en&lr=&id=PYrZAAAAQBAJ&oi=fnd&pg=PP1&dq=Hull,+R.;+Plant+virology.+2013:+Academic+press&ots=NJHjP_M4WU&sig=Ybvvy1UVPPemv2i24LhWEFmVMFE#v=onepage&q=Hull%2C R.%2C Plant virology. 2013%3A Academic press&f=false."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Avaratnarajah, C., Warrier, R., and Kuhn, R. (2008). Assembly of Viruses: Enveloped Particles. Encyclopedia of Virology, Elsevier Ltd.","DOI":"10.1016\/B978-012374410-4.00667-1"},{"key":"ref_11","unstructured":"(2021, March 01). Molecular Virology of Human Pathogenic Viruses\u20141st Edition. Available online: https:\/\/www.elsevier.com\/books\/molecular-virology-of-human-pathogenic-viruses\/ryu\/978-0-12-800838-6."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/rmv.614","article-title":"Involvement of the nucleolus in replication of human viruses","volume":"19","author":"Greco","year":"2009","journal-title":"Rev. Med. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/ismej.2011.169","article-title":"Evidence of a Robust Resident Bacteriophage Population Revealed through Analysis of the Human Salivary Virome","volume":"6","author":"Pride","year":"2011","journal-title":"ISME J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.trsl.2012.03.006","article-title":"Emerging view of the human virome","volume":"160","author":"Wylie","year":"2012","journal-title":"Transl. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/s41564-019-0523-5","article-title":"Virus Structures Constrain Transmission Modes","volume":"4","author":"Bushman","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.mp.4000484","article-title":"High Seroprevalence of Borna Virus Infection in Schizophrenic Patients, Family Members and Mental Health Workers in Taiwan","volume":"4","author":"Chen","year":"1999","journal-title":"Mol. Psychiatry"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C Virus Infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199712113372406","article-title":"Hepatitis B Virus Infection","volume":"337","author":"Lee","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000478729","article-title":"Evolution and Emergence of Pathogenic Viruses: Past, Present, and Future","volume":"60","author":"Parvez","year":"2017","journal-title":"Intervirology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1126\/science.257.5073.1073","article-title":"The Origin of Plagues: Old and New","volume":"257","author":"Krause","year":"1992","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Gorbalenya, A.E., Baker, S.C., Baric, R.S., de Groot, R.J., Drosten, C., Gulyaeva, A.A., Haagmans, B.L., Lauber, C., Leontovich, A.M., and Neuman, B.W. (2020). Severe acute respiratory syndrome-related coronavirus: The species and its viruses\u2014A statement of the Coronavirus Study Group. bioRxiv.","DOI":"10.1101\/2020.02.07.937862"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.2174\/0929867325666180518072730","article-title":"The Importance of Complying with Vaccination Protocols in Developed Countries: \u201cAnti-Vax\u201d Hysteria and the Spread of Severe Preventable Diseases","volume":"25","author":"Pandolfi","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ganti, R.S., and Chakraborty., A.K. (2020). Mechanisms underlying vaccination protocols that may optimally elicit broadly neutralizing antibodies against highly mutable pathogens. bioRxiv, 330340.","DOI":"10.1101\/2020.10.07.330340"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.smim.2013.05.001","article-title":"RNA: The new revolution in nucleic acid vaccines","volume":"25","author":"Geall","year":"2013","journal-title":"Semin. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e05007","DOI":"10.1016\/j.heliyon.2020.e05007","article-title":"Nucleic acid-based therapy for coronavirus disease 2019","volume":"6","author":"Piyush","year":"2020","journal-title":"Heliyon"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.gt.3301117","article-title":"The Promise of Nucleic Acid Vaccines","volume":"7","author":"Restifo","year":"2000","journal-title":"Gene Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"15390","DOI":"10.1002\/anie.201905687","article-title":"Potent Lymphatic Translocation and Spatial Control Over Innate Immune Activation by Polymer\u2013Lipid Amphiphile Conjugates of Small-Molecule TLR7\/8 Agonists","volume":"58","author":"Louage","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Wadhwa, A., Aljabbari, A., Lokras, A., Foged, C., and Thakur, A. (2020). Opportunities and Challenges in the Delivery of mRNA-based Vaccines. Pharmaceutics, 12, Available online: https:\/\/www.mdpi.com\/1999-4923\/12\/2\/102.","DOI":"10.3390\/pharmaceutics12020102"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.it.2017.10.002","article-title":"Improving Vaccine and Immunotherapy Design Using Biomaterials","volume":"39","author":"Bookstaver","year":"2018","journal-title":"Trends Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"18885","DOI":"10.1002\/anie.202008319","article-title":"Current Status of COVID-19 (Pre)Clinical Vaccine Development","volume":"59","author":"Ye","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"14184","DOI":"10.1021\/acs.jmedchem.0c00848","article-title":"Medicinal Chemistry and Methodological Advances in the Development of Peptide-Based Vaccines","volume":"63","author":"Sabatino","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Hemmati, M., Raoufi, E., and Fallahi, H. (2018). Predicting Candidate Epitopes on Ebola Virus for Possible Vaccine Development. Advances in Ebola Control, InTech. Available online: http:\/\/www.intechopen.com\/books\/advances-in-ebola-control\/predicting-candidate-epitopes-on-ebola-virus-for-possible-vaccine-development.","DOI":"10.5772\/intechopen.72413"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s10989-019-09918-z","article-title":"Epitope Prediction by Novel Immunoinformatics Approach: A State-of-the-art Review","volume":"26","author":"Raoufi","year":"2020","journal-title":"Int. J. Pept. Res. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Raoufi, E., Hemmati, M., Einabadi, H., and Fallahi, H. (2015, January 25\u201328). Predicting candidate epitopes on Ebolaviruse for possible vaccine development. Proceedings of the 2015 IEEE\/ACM International Conference on Advances in Social Networks Analysis and Mining 2015, Paris, France.","DOI":"10.1145\/2808797.2809370"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bj.2020.09.005","article-title":"Development of multi-epitope peptide-based vaccines against SARS-CoV-2","volume":"44","author":"Lim","year":"2020","journal-title":"Biomed. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-67749-1","article-title":"A candidate multi-epitope vaccine against SARS-CoV-2","volume":"10","author":"Kar","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"104236","DOI":"10.1016\/j.micpath.2020.104236","article-title":"Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2","volume":"145","author":"Kalita","year":"2020","journal-title":"Microb. Pathog."},{"key":"ref_38","first-page":"1","article-title":"Engineering a fidelity-variant live-attenuated vaccine for chikungunya virus","volume":"5","author":"Weiss","year":"2020","journal-title":"Vaccines"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1016\/j.vaccine.2015.08.055","article-title":"Molecular characterization of the 17D-204 yellow fever vaccine","volume":"33","author":"Salmona","year":"2015","journal-title":"Vaccine"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nm1726","article-title":"Engineering Attenuated Virus Vaccines by Controlling Replication Fidelity","volume":"14","author":"Vignuzzi","year":"2008","journal-title":"Nat. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1532-5415.1992.tb01938.x","article-title":"Reduced Infectivity of Cold-Adapted Influenza A H1N1 Viruses in the Elderly: Correlation with Serum and Local Antibodies","volume":"40","author":"Powers","year":"1992","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40475-020-00201-6","article-title":"The SARS-CoV-2 Vaccine Pipeline: An Overview","volume":"7","author":"Chen","year":"2020","journal-title":"Curr. Trop. Med. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Eckels, K.H., and Putnak, R. (2003). Formalin-inactivated Whole Virus and Recombinant Subunit Flavivirus Vaccines. Advances in Virus Research, Academic Press Inc.","DOI":"10.1016\/S0065-3527(03)61010-9"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1586\/erv.12.126","article-title":"Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome","volume":"11","author":"Jiang","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1358\/dot.2008.44.1.1131830","article-title":"Development of subunit vaccines against severe acute respiratory syndrome","volume":"44","author":"Du","year":"2008","journal-title":"Drugs Today"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12250-012-3241-1","article-title":"Developments of subunit and VLP vaccines against influenza a virus","volume":"27","author":"Deng","year":"2012","journal-title":"Virol. Sin."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1586\/14760584.2014.912134","article-title":"Current advancements and potential strategies in the development of MERS-CoV vaccines","volume":"13","author":"Zhang","year":"2014","journal-title":"Expert Rev. Vaccines"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/cmi.2015.03","article-title":"Identification of an Ideal Adjuvant for Receptor-Binding Domain-Based Subunit Vaccines against Middle East Respiratory Syndrome Coronavirus","volume":"13","author":"Zhang","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"ref_49","first-page":"29","article-title":"Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.virol.2009.07.018","article-title":"Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity","volume":"393","author":"Du","year":"2009","journal-title":"Virology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.vaccine.2006.06.084","article-title":"Immunogenicity of a receptor-binding domain of SARS coronavirus spike protein in mice: Implications for a subunit vaccine","volume":"25","author":"Zakhartchouk","year":"2007","journal-title":"Vaccine"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.virusres.2014.11.013","article-title":"Receptor-binding domain-based subunit vaccines against MERS-CoV","volume":"202","author":"Zhang","year":"2015","journal-title":"Virus Res."},{"key":"ref_53","first-page":"125","article-title":"Nanoparticles in vaccine development","volume":"1","author":"Hajizade","year":"2014","journal-title":"J. Appl. Biotechnol. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/vaccines3020320","article-title":"Vaccine Adjuvants: From 1920 to 2015 and Beyond","volume":"3","author":"Preiss","year":"2015","journal-title":"Vaccines"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1016\/j.vaccine.2019.07.098","article-title":"Adjuvant Systems for vaccines: 13 years of post-licensure experience in diverse populations have progressed the way adjuvanted vaccine safety is investigated and understood","volume":"37","year":"2019","journal-title":"Vaccine"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/2215083804666180830142648","article-title":"Plant-based Adjuvant in Vaccine Immunogenicity: A Review","volume":"4","author":"Lakshmi","year":"2018","journal-title":"Curr. Tradit. Med."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Fries, C.N., Curvino, E.J., Chen, J.-L., Permar, S.R., Fouda, G.G., and Collier, J.H. (2020). Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health. Nat. Nanotechnol., 1\u201314.","DOI":"10.1038\/s41565-020-0739-9"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2020033273","article-title":"Nanoparticles as Adjuvants in Vaccine Delivery","volume":"37","author":"Garg","year":"2020","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Nasrollahzadeh, M., Sajjadi, M., Soufi, G.J., Iravani, S., and Varma, R.S. (2020). Nanomaterials and Nanotechnology-Associated Innovations against Viral Infections with a Focus on Coronaviruses. Nanomatererials, 10, Available online: https:\/\/www.mdpi.com\/2079-4991\/10\/6\/1072.","DOI":"10.3390\/nano10061072"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41565-020-0737-y","article-title":"COVID-19 vaccine development and a potential nanomaterial path forward","volume":"15","author":"Shin","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.drudis.2020.06.020","article-title":"Emerging vaccine delivery systems for COVID-19: Functionalised Silica Nanoparticles Offer a Potentially Safe and Effective Alternative Delivery System for DNA\/RNA Vaccines and May Be Useful in the Hunt for a COVID-19 Vaccine","volume":"25","author":"Theobald","year":"2020","journal-title":"Drug Discov. Today"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Ramsey, J.M., McCloskey, A., Gaul, R., Fernandez, E.F., Sweeney, L., Greene, C.M., Macloughlin, R., and Cryan, S.-A. (2020). Respiratory Drug\/Vaccine Delivery Using Nanoparticles. AAPS Advances in the Pharmaceutical Sciences Series, Springer.","DOI":"10.1007\/978-3-030-35910-2_6"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMc2101667","article-title":"Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine","volume":"384","author":"Krammer","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.eurpolymj.2019.03.009","article-title":"Polymers for subunit vaccine delivery","volume":"114","author":"Nevagi","year":"2019","journal-title":"Eur. Polym. J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4155\/tde-2016-0008","article-title":"Vaccine delivery: Where Polymer Chemistry Meets Immunology","volume":"7","author":"Shae","year":"2016","journal-title":"Ther. Deliv."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","article-title":"Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery","volume":"27","author":"Kowalski","year":"2019","journal-title":"Mol. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Zeng, C., Zhang, C., Walker, P.G., and Dong, Y. (2020). Formulation and Delivery Technologies for mRNA Vaccines, Springer.","DOI":"10.1007\/82_2020_217"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/17425247.2020.1776259","article-title":"Polymeric nanostructure vaccines: Applications and challenges","volume":"17","author":"Peleteiro","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"35","DOI":"10.22270\/jddt.v8i5.1886","article-title":"Niosomes: Present scenario and future aspects","volume":"8","author":"Kaur","year":"2018","journal-title":"J. Drug Deliv. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"101581","DOI":"10.1016\/j.jddst.2020.101581","article-title":"Niosomes: A review on niosomal research in the last decade","volume":"56","author":"Bhardwaj","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Durak, S., Rad, M.E., Yetisgin, A.A., Sutova, H.E., Kutlu, O., Cetinel, S., and Zarrabi, A. (2020). Niosomal Drug Delivery Systems for Ocular Disease\u2014Recent Advances and Future Prospects. Nanomaterials, 10, Available online: https:\/\/www.mdpi.com\/2079-4991\/10\/6\/1191.","DOI":"10.3390\/nano10061191"},{"key":"ref_72","unstructured":"Pardakhty, A., and Moazeni, E. (2021, March 01). Nano-Niosomes in Drug, Vaccine and Gene Delivery: A Rapid Overview. Available online: http:\/\/nmj.mums.ac.ir\/article_697.html."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2014.04.015","article-title":"Nano-niosomes as nanoscale drug delivery systems: An illustrated review","volume":"185","author":"Moghassemi","year":"2014","journal-title":"J. Control. Release"},{"key":"ref_74","first-page":"25","article-title":"Niosomes: A Novel Drug Delivery System","volume":"2","author":"Arunachalam","year":"2012","journal-title":"Int. J. Nov. Trends Pharm. Sci."},{"key":"ref_75","first-page":"6847971","article-title":"Niosome: A Promising Nanocarrier for Natural Drug Delivery through Blood-Brain Barrier","volume":"2018","author":"Gharbavi","year":"2018","journal-title":"Adv. Pharmacol. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Danaei, M., Dehghankhold, M., Ataei, S., Davarani, F.H., Javanmard, R., Dokhani, A., Khorasani, S., and Mozafari, M.R. (2018). Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. Pharmaceutics, 10, Available online: http:\/\/www.mdpi.com\/1999-4923\/10\/2\/57.","DOI":"10.3390\/pharmaceutics10020057"},{"key":"ref_77","first-page":"711","article-title":"Liposomes: An Overview of Manufacturing Techniques","volume":"10","author":"Mozafari","year":"2005","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2174\/157341311795542453","article-title":"Liposomes: A Review of Manufacturing Techniques and Targeting Strategies","volume":"7","author":"Maherani","year":"2011","journal-title":"Curr. Nanosci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-60327-360-2_2","article-title":"Nanoliposomes: Preparation and Analysis","volume":"605","author":"Mozafari","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"50","DOI":"10.29161\/PT.v6.i2.2018.50","article-title":"An Updated Review On: Liposomes as Drug Delivery System","volume":"6","author":"Sharma","year":"2018","journal-title":"PharmaTutor"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/00914037.2017.1332623","article-title":"Overview of preparation methods of polymeric and lipid-based (niosome, solid lipid, liposome) nanoparticles: A comprehensive review","volume":"67","author":"Amoabediny","year":"2017","journal-title":"Int. J. Polym. Mater."},{"key":"ref_82","first-page":"457","article-title":"Iscom, a Novel Structure for Antigenic Presentation of Membrane Proteins from Enveloped Viruses","volume":"308","author":"Morein","year":"1984","journal-title":"Nat. Cell Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s00705-019-04273-2","article-title":"Adjuvant activity of multimolecular complexes based on Glycyrrhiza glabra saponins, lipids, and influenza virus glycoproteins","volume":"164","author":"Alexyuk","year":"2019","journal-title":"Arch. Virol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.4161\/hv.27907","article-title":"Reduced MyD88 Dependency of ISCOMATRIX\u2122 Adjuvant in a DNA Prime-Protein Boost HIV Vaccine","volume":"10","author":"Pouliot","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2174\/2211738507666191024162042","article-title":"Nanoparticles and Vaccine Development","volume":"8","author":"Kheirollahpour","year":"2020","journal-title":"Pharm. Nanotechnol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.addr.2004.09.006","article-title":"ISCOMATRIX\u00ae adjuvant for antigen delivery","volume":"57","author":"Pearse","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.addr.2007.05.017","article-title":"Nanotechnology in vaccine delivery","volume":"60","author":"Peek","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ijpharm.2017.06.037","article-title":"Tocosome: Novel drug delivery system containing phospholipids and tocopheryl phosphates","volume":"528","author":"Mozafari","year":"2017","journal-title":"Int. J. Pharm."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"LB79","DOI":"10.1096\/fasebj.20.5.LB79-d","article-title":"Tocopheryl phosphate, a novel natural form of vitamin E: In vitro and in vivo studies","volume":"20","author":"Azzi","year":"2006","journal-title":"FASEB J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.freeradbiomed.2005.05.016","article-title":"\u03b1-Tocopheryl phosphate: A novel, natural form of vitamin E","volume":"39","author":"Gianello","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Zarrabi, A., Alipoor, A.A.M., Khorasani, S., Mohammadabadi, M.R., Jamshidi, A., Torkaman, S., Taghavi, E., Mozafari, M.R., and Rasti, B. (2020). Nanoliposomes and Tocosomes as Multifunctional Nanocarriers for the Encapsulation of Nutraceutical and Dietary Molecules. Molecules, 25, Available online: https:\/\/www.mdpi.com\/1420-3049\/25\/3\/638.","DOI":"10.3390\/molecules25030638"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbrc.2004.04.028","article-title":"Modulation of cell proliferation and gene expression by \u03b1-tocopheryl phosphates: Relevance to atherosclerosis and inflammation","volume":"318","author":"Munteanu","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1440-1681.2010.05356.x","article-title":"Effect of tocopheryl phosphate on key biomarkers of inflammation: Implication in the reduction of atherosclerosis progression in a hypercholesterolaemic rabbit model","volume":"37","author":"Libinaki","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_94","first-page":"1277","article-title":"\u03b1-tocopheryl phosphate suppresses tumor invasion concurrently with dynamic morphological changes and delocalization of cortactin from invadopodia","volume":"35","author":"Saitoh","year":"2009","journal-title":"Int. J. Oncol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.freeradbiomed.2011.03.021","article-title":"\u03b1-Tocopheryl phosphate: Uptake, hydrolysis, and antioxidant action in cultured cells and mouse","volume":"50","author":"Nishio","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4155\/tde-2016-0006","article-title":"mRNA vaccine delivery using lipid nanoparticles","volume":"7","author":"Reichmuth","year":"2016","journal-title":"Ther. Deliv."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/14760584.2015.986104","article-title":"Lipid-based mRNA vaccine delivery systems","volume":"14","author":"Midoux","year":"2014","journal-title":"Expert Rev. Vaccines"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Corth\u00e9sy, B., and Bioley, G. (2018). Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection. Front. Immunol., 9, Available online: www.frontiersin.org.","DOI":"10.3389\/fimmu.2018.00431"},{"key":"ref_99","first-page":"261","article-title":"Vaccines Prevent Many Millions of Illnesses and Save Numerous Lives Every Year","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Publ. Gr."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e1530","DOI":"10.1002\/wnan.1530","article-title":"Nanoscale platforms for messenger RNA delivery","volume":"11","author":"Li","year":"2019","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.scp.2017.07.002","article-title":"Lipid nanoparticles: Different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery","volume":"6","author":"Ganesan","year":"2017","journal-title":"Sustain. Chem. Pharm."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","article-title":"Modified mRNA Vaccines Protect against Zika Virus Infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.06.040","article-title":"Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease","volume":"170","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2010.01.036","article-title":"Endocytosis of nanomedicines","volume":"145","author":"Sahay","year":"2010","journal-title":"J. Control. Release"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"13959","DOI":"10.1074\/jbc.M111.288746","article-title":"Low-density Lipoprotein Receptor Represents an Apolipoprotein E-independent Pathway of A\u03b2 Uptake and Degradation by Astrocytes","volume":"287","author":"Basak","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.addr.2019.08.004","article-title":"Brief update on endocytosis of nanomedicines","volume":"144","author":"Patel","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"100766","DOI":"10.1016\/j.nantod.2019.100766","article-title":"Three decades of messenger RNA vaccine development","volume":"28","author":"Verbeke","year":"2019","journal-title":"Nano Today"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nbt.1602","article-title":"Rational Design of Cationic Lipids for siRNA Delivery","volume":"28","author":"Semple","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"8657","DOI":"10.1002\/ange.201203263","article-title":"Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo","volume":"124","author":"Jayaraman","year":"2012","journal-title":"Angew. Chem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1021\/acs.nanolett.9b04246","article-title":"Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering","volume":"20","author":"Billingsley","year":"2020","journal-title":"Nano Lett."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Zeng, C., Hou, X., Yan, J., Zhang, C., Li, W., Zhao, W., Du, S., and Dong, Y. (2020). Leveraging mRNAs sequences to express SARS-CoV-2 antigens in vivo. bioRxiv Prepr. Serv. Biol.","DOI":"10.1101\/2020.04.01.019877"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid Nanoparticle Systems for Enabling Gene Therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jconrel.2019.01.001","article-title":"Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo","volume":"295","author":"Sato","year":"2019","journal-title":"J. Control Release"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ymthe.2018.03.010","article-title":"A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates","volume":"26","author":"Sabnis","year":"2018","journal-title":"Mol. Ther."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/0300985817738095","article-title":"Safety Evaluation of Lipid Nanoparticle\u2013Formulated Modified mRNA in the Sprague-Dawley Rat and Cynomolgus Monkey","volume":"55","author":"Sedic","year":"2017","journal-title":"Veter- Pathol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addr.2016.01.022","article-title":"The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery","volume":"99","author":"Cheng","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bbamem.2005.02.001","article-title":"Stabilized plasmid\u2013lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression","volume":"1669","author":"Ambegia","year":"2005","journal-title":"Biochim. Biophys. Acta BBA Biomembr."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jconrel.2005.06.014","article-title":"Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids","volume":"107","author":"Heyes","year":"2005","journal-title":"J. Control. Release"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/s41587-019-0247-3","article-title":"Delivery of mRNA Vaccines with Heterocyclic Lipids Increases Anti-Tumor Efficacy by STING-Mediated Immune cell Activation","volume":"37","author":"Miao","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1556-276X-8-102","article-title":"Liposome: Classification, Preparation, and Applications","volume":"8","author":"Akbarzadeh","year":"2013","journal-title":"Nanoscale Res. Lett."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA Delivery to Dendritic Cells Exploits Antiviral Defence for Cancer Immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.antiviral.2017.03.009","article-title":"Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine","volume":"142","author":"Borrego","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Chen, D., Love, K.T., Chen, Y., Eltoukhy, A.A., Kastrup, C., Sahay, G., Jeon, A., Dong, Y., Whitehead, K.A., and Anderson, D.G. (2012). Rapid Discovery of Potent siRNA-Containing Lipid Nanoparticles Enabled by Controlled Microfluidic Formulation. J. Am. Chem. Soc., 134, Available online: https:\/\/pubs.acs.org\/doi\/abs\/10.1021\/ja301621z.","DOI":"10.1021\/ja301621z"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"eaaw6647","DOI":"10.1126\/sciimmunol.aaw6647","article-title":"A Lipid-Encapsulated mRNA Encoding a Potently Neutralizing Human Monoclonal Antibody Protects against Chikungunya Infection","volume":"4","author":"Kose","year":"2019","journal-title":"Sci. Immunol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e1804788","DOI":"10.1002\/adma.201804788","article-title":"Lipid Nanovesicles by Microfluidics: Manipulation, Synthesis, and Drug Delivery","volume":"31","author":"Liu","year":"2019","journal-title":"Adv. Mater."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Belliveau, N.M., Huft, J., Lin, P.J., Chen, S., Leung, A.K., Leaver, T.J., Wild, A.W., Lee, J.B., Taylor, R.J., and Tam, Y.K. (2012). Microfluidic synthesis of highly potent limit-size lipid nanoparticles for in vivo delivery of siRNA. Mol. Ther. Nucleic Acids, e37.","DOI":"10.1038\/mtna.2012.28"},{"key":"ref_127","first-page":"E3351","article-title":"Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles","volume":"115","author":"Arteta","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Damiati, S., Kompella, U., Damiati, S., and Kodzius, R. (2018). Microfluidic Devices for Drug Delivery Systems and Drug Screening. Genes, 9, Available online: http:\/\/www.mdpi.com\/2073-4425\/9\/2\/103.","DOI":"10.3390\/genes9020103"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.micron.2007.06.013","article-title":"Microscopical investigations of nisin-loaded nanoliposomes prepared by Mozafari method and their bacterial targeting","volume":"38","author":"Colas","year":"2007","journal-title":"Micron"},{"key":"ref_130","first-page":"243","article-title":"Formation and characterisation of non-toxic anionic liposomes for delivery of therapeutic agents to the pulmonary airways","volume":"7","author":"Mozafari","year":"2002","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_131","first-page":"342","article-title":"Development of non-toxic liposomal formulations for gene and drug delivery to the lung","volume":"10","author":"Mozafari","year":"2002","journal-title":"Technol. Health Care"},{"key":"ref_132","unstructured":"Mozafari, M.R. (2005). Method and Apparatus for Producing Carrier Complexes. (GB0404993,8), Patent Application."},{"key":"ref_133","unstructured":"Mozafari, M.R. (2010). Method for the Preparation of Micro- and Nano-Sized Carrier Systems for the Encapsulation of Bioactive Substances. (12\/790,991), U.S. Patent Application."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08982104.2013.810644","article-title":"Formulation and characterization of nanoliposomal 5-fluorouracil for cancer nanotherapy","volume":"24","author":"ElMeshad","year":"2013","journal-title":"J. Liposome Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/fsn3.1306","article-title":"Manufacturing of nanoliposomal extract from Sargassum boveanum algae and investigating its release behavior and antioxidant activity","volume":"8","author":"Savaghebi","year":"2020","journal-title":"Food Sci. Nutr."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/08982104.2013.839702","article-title":"Optimization on preparation condition of polyunsaturated fatty acids nanoliposome prepared by Mozafari method","volume":"24","author":"Rasti","year":"2013","journal-title":"J. Liposome Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0005-2736(93)90115-G","article-title":"Subcutaneous administration of liposomes: A comparison with the intravenous and intraperitoneal routes of injection","volume":"1150","author":"Allen","year":"1993","journal-title":"Biochim. Biophys. Acta BBA Biomembr."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(01)00150-8","article-title":"The physiology of the lymphatic system","volume":"50","author":"Swartz","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0005-2736(97)00275-7","article-title":"Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: IV. Fate of liposomes in regional lymph nodes","volume":"1370","author":"Oussoren","year":"1998","journal-title":"Biochim. Biophys. Acta BBA Biomembr."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jconrel.2009.10.022","article-title":"Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen","volume":"142","author":"Bramwell","year":"2010","journal-title":"J. Control. Release"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1021\/mp100208f","article-title":"Comparison of the depot effect and immunogenicity of liposomes based on DDA, DC-Chol and DOTAP: Prolonged liposome retention mediates stronger Th1 responses","volume":"8","author":"Christensen","year":"2011","journal-title":"Mol Pharm."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0005-2736(92)90061-P","article-title":"The role of surface charge and hydrophilic groups on liposome clearance in vivo","volume":"1103","author":"Gabizon","year":"1992","journal-title":"Biochim. Biophys. Acta BBA Biomembr."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/18756786MTA4iMTAi3","article-title":"Antimicrobial Applications of Nanoliposome Encapsulated Silver Nanoparticles: A Potential Strategy to Overcome Bacterial Resistance","volume":"17","author":"Mozafari","year":"2021","journal-title":"Curr. Nanosci."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ymthe.2005.09.014","article-title":"Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes","volume":"13","author":"Judge","year":"2006","journal-title":"Mol. Ther."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/wnan.1339","article-title":"Anti-PEG immunity: Emergence, characteristics, and unaddressed questions","volume":"7","author":"Yang","year":"2015","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1182\/blood-2008-05-155176","article-title":"The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement","volume":"112","author":"Caminschi","year":"2008","journal-title":"Blood"},{"key":"ref_147","first-page":"580","article-title":"Lectin Protein as a Promising Component to Functionalize Micelles, Liposomes and Lipid NPs against Coronavirus","volume":"8","author":"Alavi","year":"2020","journal-title":"Biomedicine"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1189\/jlb.0512231","article-title":"The mannose receptor","volume":"92","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0092-8674(00)80693-5","article-title":"Identification of DC-SIGN, a Novel Dendritic Cell\u2013Specific ICAM-3 Receptor that Supports Primary Immune Responses","volume":"100","author":"Geijtenbeek","year":"2000","journal-title":"Cell"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/375151a0","article-title":"The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing","volume":"375","author":"Jiang","year":"1995","journal-title":"Nature"},{"key":"ref_151","first-page":"71","article-title":"Langerin, a Novel C-Type Lectin Specific to Langerhans Cells, Is an Endocytic Receptor that Induces the Formation of Birbeck Granules","volume":"12","author":"Valladeau","year":"2000","journal-title":"Immunology"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"7221","DOI":"10.1016\/j.biomaterials.2012.06.049","article-title":"Microparticle surface modifications targeting dendritic cells for non-activating applications","volume":"33","author":"Lewis","year":"2012","journal-title":"Biomaterials"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1172\/JCI119825","article-title":"Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein","volume":"100","author":"Karanikas","year":"1997","journal-title":"J. Clin. Investig."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1021\/bc8002524","article-title":"Influence of Ligand Valency on the Targeting of Immature Human Dendritic Cells by Mannosylated Liposomes","volume":"19","author":"Espuelas","year":"2008","journal-title":"Bioconj. Chem."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1590\/S1984-82502013000700009","article-title":"Glycodendritic structures: Tools to interact with DC-SIGN","volume":"49","author":"Reina","year":"2013","journal-title":"Braz. J. Pharm. Sci."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3109\/1061186X.2010.504262","article-title":"Selective gene delivery in dendritic cells with mannosylated and histidylated lipopolyplexes","volume":"19","author":"Perche","year":"2010","journal-title":"J. Drug Target."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.nano.2010.12.010","article-title":"Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA","volume":"7","author":"Perche","year":"2011","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1126\/science.1136080","article-title":"Differential Antigen Processing by Dendritic Cell Subsets in Vivo","volume":"315","author":"Dudziak","year":"2007","journal-title":"Science"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/5\/520\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:57:44Z","timestamp":1760162264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/5\/520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,6]]},"references-count":158,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["biomedicines9050520"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9050520","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,6]]}}}